Lv2
120 积分 2026-03-30 加入
Engineering CAR-based cellular immunotherapy for hepatocellular carcinoma: Current barriers, innovative strategies, and future directions
7小时前
已关闭
Chimeric antigen receptor therapy for hepatocellular carcinoma
7小时前
已关闭
Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management
1个月前
已完结
Uncovering immune dysfunction in ACLF: cellular mechanisms, molecular pathways, and therapeutic frontiers
1个月前
已关闭
Is liver steatosis a disease or the emperor’s new clothes?
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
1个月前
已完结
Lifespan approaches for the prevention and management of steatotic liver disease
2个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
3个月前
已完结
Recompensation in decompensated cirrhosis
3个月前
已完结
皖公网安备34019202002308
